Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis.

Literature DB >> 9431982

Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis.

M R Oggioni, G Pozzi, P E Valensin, P Galieni, C Bigazzi.

Abstract

Entities: Disease Species

Mesh：

Year: 1998 PMID： 9431982 PMCID： PMC124869

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

× No keyword cloud information.

9 in total

1. "Bacillus subtilis" infection in a patient submitted to a bone marrow transplantation.

Authors: E Velasco; C A Martins; D Tabak; L F Bouzas
Journal: Rev Paul Med Date: 1992 May-Jun

Review 2. On the safety of Bacillus subtilis and B. amyloliquefaciens: a review.

Authors: A S de Boer; B Diderichsen
Journal: Appl Microbiol Biotechnol Date: 1991-10 Impact factor: 4.813

3. Atypical meningitis complicating a penetrating head injury.

Authors: M Thomas; H Whittet
Journal: J Neurol Neurosurg Psychiatry Date: 1991-01 Impact factor: 10.154

Review 4. Bacillus subtilis as a cause of cholangitis in polycystic kidney and liver disease.

Authors: F Wallet; V Crunelle; M Roussel-Delvallez; A Fruchart; P Saunier; R J Courcol
Journal: Am J Gastroenterol Date: 1996-07 Impact factor: 10.864

5. [Bacillus subtilis infections].

Authors: T Kiss; A Gratwohl; R Frei; B Osterwalder; A Tichelli; B Speck
Journal: Schweiz Rundsch Med Prax Date: 1988-11-08

6. Antibiotic susceptibility as a taxonomic characteristic of the genus Bacillus.

Authors: O N Reva; V A Vyunitskaya; S R Reznik; I A Kozachko; V V Smirnov
Journal: Int J Syst Bacteriol Date: 1995-04

7. Determination of the spectrum of antibiotic resistance of the "Bacillus subtilis" strains of Enterogermina.

Authors: F Ciffo
Journal: Chemioterapia Date: 1984-02

8. Nosocomial bacteremia caused by Bacillus species.

Authors: V Richard; P Van der Auwera; R Snoeck; D Daneau; F Meunier
Journal: Eur J Clin Microbiol Infect Dis Date: 1988-12 Impact factor: 3.267

9. Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy.

Authors: P Mazza; F Zani; P Martelli
Journal: Boll Chim Farm Date: 1992-12

9 in total

36 in total

Review 1. Risk and safety of probiotics.

Authors: Shira Doron; David R Snydman
Journal: Clin Infect Dis Date: 2015-05-15 Impact factor: 9.079

Review 2. Motifs and interface amino acid-mediated regulation of amyloid biogenesis in microbes to humans: potential targets for intervention.

Authors: Ayesha Z Beg; Asad U Khan
Journal: Biophys Rev Date: 2020-09-15

3. Inhibitory Mechanism on Combination of Phytic Acid with Methanolic Seed Extract of Syzygium cumini and Sodium Chloride over Bacillus subtilis.

Authors: Alok Kumar Yadav; Preeti Sirohi; Saurabh Saraswat; Manjoo Rani; Manish Pratap Singh; Sameer Srivastava; Nand K Singh
Journal: Curr Microbiol Date: 2018-02-20 Impact factor: 2.188

4. Non-canonical proteolytic activation of human prothrombin by subtilisin from Bacillus subtilis may shift the procoagulant-anticoagulant equilibrium toward thrombosis.

Authors: Giulia Pontarollo; Laura Acquasaliente; Daniele Peterle; Roberta Frasson; Ilaria Artusi; Vincenzo De Filippis
Journal: J Biol Chem Date: 2017-07-06 Impact factor: 5.157

Review 5. Safety assessment of probiotics for human use.

Authors: Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal: Gut Microbes Date: 2010-03-04